CTC Alternative Strategies »

Tscan Therapeutics shares owned by CTC Alternative Strategies

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by CTC Alternative Strategies from 13F filings

Historical chart of CTC Alternative Strategies investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by CTC Alternative Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by CTC Alternative Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $87k 11k 7.94

More positions owned by CTC Alternative Strategies

Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Bitcoin Tr SHS
Ishares Tr Tips Bd Etf (TIP)
Ishares Tr Mbs Etf (MBB)
Callon Petroleum (CPE)
Ishares Tr Iboxx Hi Yd Etf (HYG)
CRH Ord (CRH)
Dell Technologies CL C (DELL)
Packaging Corporation of America (PKG)
Abbott Laboratories (ABT)
Kimberly-Clark Corporation (KMB)
Spirit Aerosystems Hldgs Com Cl A (SPR)
Martin Marietta Materials (MLM)
Raymond James Financial (RJF)
Genuine Parts Company (GPC)

View all positions for CTC Alternative Strategies

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
Adage Capital Partners GP
BVF
Baker Bros. Advisors
Propel Bio Management
Vanguard Group
BlackRock
Deer Management
Alphabet
Simplify Asset Management
Geode Capital Management
Millennium Management
Laurion Capital Management
Susquehanna International

View all funds holding Tscan Therapeutics